NGVT
Get informed when a big investor buys or sells
+ FollowOvervalued by 76.1% based on the discounted cash flow analysis.
| Market cap | $2.36 Billion |
|---|---|
| Enterprise Value | $3.47 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.61 |
| Beta | 1.24 |
| Outstanding Shares | 35,300,000 |
| P/E Ratio | -18.73 |
|---|---|
| PEG | -9.77 |
| Price to Sales | 1.97 |
| Price to Book Ratio | 66.97 |
| Enterprise Value to Revenue | 2.86 |
| Enterprise Value to EBIT | -33.24 |
| Enterprise Value to Net Income | -28 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 30.96 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1871▼ 1.68% |
|---|---|
| Total Calls | 17,100▼ 14.93% |
| Total Puts | 3,200▼ 21.95% |
Holdings and activity of institutional investors.
| Ownership % | 100.16%▼ 2.45% |
|---|---|
| Total Invested | $2.55B▲ 15.52% |
| Investors Holding | 304▲ 2.00% |
No data
Ingevity provides specialty chemicals, high-performance carbon materials and engineered polymers that purify, protect and enhance the world around us. Through a team of talented and experienced people, Ingevity develops, manufactures, an...